---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-085361"
form_type: "8-K"
ticker: null
cik: "0000786947"
company_name: "ACURA PHARMACEUTICALS, INC"
filed_at: "2023-07-28T23:59:59+00:00"
generated_at: "2026-06-12T23:26:02.177754+00:00"
event_type: "debt"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Acura receives $250K related-party loan; warns may need to terminate operations by end of August 2023

## Summary
- Received $250K loan from AD Pharma; total note now $3,919,279, matures Dec 31, 2023 at 5.25%.
- AD Pharma holds 66% of common; its managing partner Mr. Schutte directly owns 14%.
- Proceeds cover operations only through August 2023; no assurance of additional financing; may need to scale back or seek bankruptcy.
- Default interest rate 7.5% per annum on overdue amounts.

## SEC filing metadata
- accession: 0001104659-23-085361
- form_type: 8-K
- cik: 0000786947
- company_name: ACURA PHARMACEUTICALS, INC
- filed_at: 2023-07-28T23:59:59+00:00
- event_type: debt
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 2.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/786947/000110465923085361/0001104659-23-085361-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/786947/000110465923085361/tm2322359d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-085361
- JSON: https://secwatch.observer/filing/0001104659-23-085361.json
- Plain text: https://secwatch.observer/filing/0001104659-23-085361.txt

## Key facts
- Debt Financings
  ACURA PHARMACEUTICALS, INC incurred loan of $250,000 with Abuse Deterrent Pharma, LLC at 5.25% maturing December 31, 2023.
  - Instrument: loan
  - Principal: $250,000
  - Counterparty: Abuse Deterrent Pharma, LLC
  - Rate: 5.25%
  - Maturity: December 31, 2023
  - Event: incurrence
  source text: On July 28, 2023 we received a $250,000 loan from Abuse Deterrent Pharma, LLC ("AD Pharma").
  evidence_url: https://www.sec.gov/Archives/edgar/data/786947/000110465923085361/0001104659-23-085361-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.